Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
519
datasets available to search
ShareScore release 0.9.0
Dataset results
519 results for “lower extremity”
Prosthetic Limb Movement Feedback for Upper and Lower Extremity Amputees
ClinicalTrials.gov study NCT03135847. IPD Sharing: YES. Countries: 0. Publications: 0.
Lower Extremities Muscle Strength and Power Thresholds Required for Mobility Independence
ClinicalTrials.gov study NCT01374334. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparison of Anesthetic Modalities on Hemodynamic Stability and Postoperative Pain in Diabetic Foot Patients Undergoing Minor Lower Extremity Amputation
ClinicalTrials.gov study NCT02440282. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Investigation of the Relationship Between Lower and Upper Extremity Selective Motor Control and Sensory Functions in Children With Spastic Cerebral Palsy
ClinicalTrials.gov study NCT05696535. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Reliability and Validity of the Finnish Visual Analogue Scale Foot and Ankle and the Lower Extremity Functional Scale
ClinicalTrials.gov study NCT02536651. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen
ClinicalTrials.gov study NCT05625711. IPD Sharing: NO. Countries: 0. Publications: 0.
The Influence of Hip Replacement on Lower Extremity Hemodynamics in Crowe IV Hip Dysplasia Patient
ClinicalTrials.gov study NCT04157842. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
ClinicalTrials.gov study NCT01165892. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease
ClinicalTrials.gov study NCT07139639. IPD Sharing: YES. Countries: 0. Publications: 0.
Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States
ClinicalTrials.gov study NCT02857764. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Antibiotic Use & Open Fracture of the Lower Extremity
ClinicalTrials.gov study NCT05267977. IPD Sharing: NO. Countries: 1. Publications: 0.
Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity
ClinicalTrials.gov study NCT03903653. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease
ClinicalTrials.gov study NCT03320447. IPD Sharing: NO. Countries: 0. Publications: 0.
Psychometric Evaluation of the Multidimensional Scale of Perceived Social Support in Lower Extremity Amputation
ClinicalTrials.gov study NCT07379320. IPD Sharing: NO. Countries: 0. Publications: 0.
Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities
ClinicalTrials.gov study NCT00751283. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article "Automatic Planning of the Lower-Extremities for Total Marrow Irradiation Using Volumetric Modulated Arc Therapy"
<p>This record contains raw data related to article "Automatic Planning of the Lower-Extremities for Total Marrow Irradiation Using Volumetric Modulated Arc Therapy"</p> <p><strong>Abstract</strong></p> <p><strong>Purpose</strong>: Total marrow (and lymphoid) irradiation (TMI-TMLI) is limited by the couch travel range of modern linacs, which forces to split the treatment delivery into two plans with opposite orientations: a head-first supine upper-body plan, and a feet-first supine lower-extremities plan. A specific field junction is thus needed to obtain adequate target coverage in the overlap region of the two plans. In this study, an automatic procedure was developed for field junction creation and lower-extremities plan optimization.</p> <p><strong>Methods</strong>: Ten patients treated with TMI-TMLI at our institution were selected retrospectively. The planning of the lower-extremities was performed automatically. Target volume parameters (CTV_J-V<sub>98%</sub>>98%) at the junction region and several dose statistics (D<sub>98%</sub>, D<sub>mean</sub>, and D<sub>2%</sub>) were compared between automatic and manual plans. The Modulation Complexity Score (MCS) was used to assess plan complexity.</p> <p><strong>Results</strong>: The automatic procedure required 60-90 minutes, depending on the case. All automatic plans achieved clinically acceptable dosimetric results (CTV_J-V<sub>98%</sub>>98%), with significant differences found at the junction region, where D<sub>mean </sub>and D<sub>2% </sub>increased on average by 2.4% (p<0.03) and 3.0% (p<0.02), respectively. Similar plan complexity was observed (median MCS=0.12). Since March 2022 the automatic procedure has been introduced in our clinic, reducing the TMI-TMLI simulation-to-delivery schedule by 2 days.</p> <p><strong>Conclusions</strong>: The developed procedure allowed to streamline the treatment planning of TMI-TMLI, increasing efficiency and standardization, preventing human errors, while maintaining the dosimetric plan quality and complexity of manual plans. Automated strategies can simplify the future adoption and clinical implementation of TMI-TMLI treatments in new centers.</p> <p> </p>
Platelet Rich Plasma Study in Lower Extremity Bypass Surgery
ClinicalTrials.gov study NCT00517452. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article "Functional changes in the lower extremity after non-immersive virtual reality and physiotherapy following stroke"
<p>DATASET #1</p> <p>Variable description of the dataset from publication DOI: 10.2340/16501977-2763<br> ID_PATIENT = unique identifier of subject in the original clinical database<br> ID_EVO4 = unique identifier of subject in the original device database for kinematic analysis<br> AGE = given age of the subject at the time of assessment<br> GENDER = given gender of the subject at the time of assessment<br> ID_LESION = unique identifier of aetiology of the brain lesion (1 = ischemic lesion; 2 = haemorrhagic lesion)<br> LESION_SIDE = unique identifier of hemisphere affected by the brain lesion (1 = right; 2 = left)<br> MONTHS FROM LESION = time distance between time of assessment and stroke onset<br> FM LE_PRE = Fugl-Meyer Assessment scale, lower limb section detected before treatment. This outcome measure assesses the impairment of motor function at the lower limb after stroke.<br> MAS_PRE = FM LE_PRE = Modified Ashworth Scale at the ankle, knee and hip, detected before treatment. This outcome measure assesses the reaction to fast elongation of muscles.<br> FIM_pre = Functional Independence Measure detected before treatment. This outcome measure assesses independence of the subject in the activities of daily living.<br> 10MTWT_PRE = 10 meters walking test detected before treatment. This outcome measure assesses the time needed to cover 10 meters by walking.<br> BERG_PRE = Berg Balance Scale detected before treatment. This outcome measure assesses impairment of balance function.<br> FAC_PRE = BERG_PRE = Functional Ambulation Category detected before treatment. This outcome measure classifies autonomy in ambulation function.<br> FM LE_POST = Fugl-Meyer Assessment scale, lower limb section detected after treatment. This outcome measure assesses the impairment of motor function at the lower limb after stroke.<br> MAS_ POST = FM LE_PRE = Modified Ashworth Scale at the ankle, knee and hip, detected after treatment. This outcome measure assesses the reaction to fast elongation of muscles.<br> FIM_ POST = Functional Independence Measure detected after treatment. This outcome measure assesses independence of the subject in the activities of daily living.<br> 10MTWT_ POST = 10 meters walking test detected after treatment. This outcome measure assesses the time needed to cover 10 meters by walking.<br> BERG_ POST = Berg Balance Scale detected after treatment. This outcome measure assesses impairment of balance function.<br> FAC_ POST = BERG_PRE = Functional Ambulation Category detected after treatment. This outcome measure classifies autonomy in ambulation function.<br> spatial error_PRE = this kinematic measure is the difference (computed as an area, mm2) between the trajectory performed by the patient in executing a standard motor task and the ideal one that should be performed.<br> Time_PRE = this kinematic measure is the overall time (s) needed by the patient to perform a standard motor task, before the treatment.<br> Lenght_PRE = this kinematic measure is the overall distance (mm) covered by the patient to perform a standard motor task, before the treatment.<br> speed_PRE = this kinematic measure is the mean velocity (m/s) expressed by the patient to perform a standard motor task, before the treatment.<br> peak_PRE = this kinematic measure is the jerk (m/s2) expressed by the patient to perform a standard motor task, before the treatment.<br> spatial error_POST = this kinematic measure is the difference (computed as an area, mm2) between the trajectory performed by the patient in executing a standard motor task and the ideal one that should be performed.<br> Time_ POST = this kinematic measure is the overall time (s) needed by the patient to perform a standard motor task, before the treatment.<br> Lenght_ POST = this kinematic measure is the overall distance (mm) covered by the patient to perform a standard motor task, before the treatment.<br> speed_ POST = this kinematic measure is the mean velocity (m/s) expressed by the patient to perform a standard motor task, before the treatment.<br> peak_ POST = this kinematic measure is the jerk (m/s2) expressed by the patient to perform a standard motor task, before the treatment.</p>
Validation of a Bluetooth-Enabled Load Cell for Objective and Accessible Assessment of Lower Extremity Strength
<p>Raw data used in validating a novel rehabilitation system (PhyzViz) against an isokinetic dynamometer (Biodex, gold standard) for plantarflexion maximal voluntary isometric contractions (MVICs).</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.